Urine cytology in kidney cancer — what it finds, and what it misses
Urine cytology is a microscope test on the cells your urinary tract sheds into your urine. It is often called urothelial cytology, and that word is the key to it: it looks at the lining of the tract, so it can find a urothelial carcinoma of the renal pelvis — and it cannot find the common kidney cancer that grows from the filtering tissue of the kidney itself. This page explains what the test is for, what each result on the report means, and what happens next.
- It reads the lining, not the kidney — cells shed from the renal pelvis, ureter, bladder and urethra, which is why it is a renal pelvis test rather than a general kidney cancer test.
- Strong on high-grade, weak on low-grade — it is most useful for aggressive tumours and for flat carcinoma in situ; low-grade tumours shed near-normal cells and are often missed.
- A clear result does not close the question — it lowers suspicion, but imaging of the urinary tract, not the urine pot, is what rules a tumour in or out.
- In-house at CION — the urine and blood tests, the ultrasound, CT and MRI and the tumour-board review sit with our own team; camera procedures are coordinated with specialist urology partners.
on Panel
Telangana & AP
Treated
(800+ reviews)
What urine cytology is — and which kidney cancers it can actually find
Start with why the test was ordered. Most people are sent for urine cytology because there is blood in the urine, visible or picked up on a dipstick, or because a scan has shown something in the renal pelvis. Blood in the urine is always worth checking promptly, even a single painless episode that clears up on its own. It is also, far more often than not, caused by something other than cancer — infection, a stone, an enlarged prostate or vigorous exercise. Being asked for a urine sample is a step in answering the question. It is not an answer, and it is not a verdict.
What the test actually is — your urinary tract is lined with a layer of cells called the urothelium, and that lining continuously sheds cells into the urine. A cytology sample is spun down, fixed and stained, and a pathologist looks at those loose cells under a microscope for changes in size, shape and in the appearance of the nucleus. There is no needle and no scan. The whole test is the urine you have already passed.
The distinction that matters most — the two cancers that involve a kidney are not the same disease, and only one of them shows up in urine. Renal cell carcinoma, the common kidney cancer, grows from the filtering tubules deep inside the kidney and does not usually shed cells into the urine, so cytology is not a test for it. Urothelial carcinoma of the renal pelvis grows from the lining at the centre of the kidney where urine collects, and it is a close relative of bladder cancer. That one can shed cells you can see. If your report or your consultation mentions the renal pelvis, the ureter or the word urothelial, our page on urothelial carcinoma of the renal pelvis is the one to read next.
Where cytology is strong, and where it is not — high-grade tumours shed cells that look clearly abnormal, and flat carcinoma in situ, which is difficult to see even with a camera, often announces itself in the urine. Low-grade tumours are the opposite: the cells they shed look close to normal, so they are frequently missed. A tumour sitting high in the renal pelvis may also shed very little into a voided sample. This is why cytology is used as one voice in the work-up rather than as the deciding test.
What it is not — it is not a screening test. There is no case for having your urine checked for cancer cells because you are worried and well, with no symptoms and a normal scan. It is also not the same as the routine urine test your GP does for infection, and not the same as the kidney-function bloods and urine protein checks used to monitor the kidney itself. We separate all of those on our page about blood and urine tests in kidney cancer. The wider picture — types, stages, risk factors and symptoms — sits on our kidney cancer guide.
Four situations account for most cytology requests. Recognising yours makes the conversation with your doctor much shorter:
- Blood in the urine that needs explaining. Visible bleeding, or red cells found on a dipstick or microscopy, with cytology sent alongside imaging of the whole urinary tract rather than instead of it.
- A filling defect in the renal pelvis or ureter on a scan. A shadow where the contrast should flow freely raises the possibility of a urothelial tumour, and cytology adds a second line of evidence.
- Symptoms that point at the drainage system. Loin pain from an obstructed kidney, or clots passed in the urine, where the lining rather than the kidney substance is under suspicion.
- Follow-up after a known urothelial cancer. Someone already treated for a tumour of the bladder or upper tract, where surveillance combines cytology with imaging and camera checks.
If you have been given a cytology result and nobody has explained what it changes, ask. Book a free consultation and have the report and the scan gone through with you properly.
Did you know?
The most common kidney cancer does not show up in a urine test. Renal cell carcinoma grows from the filtering tubules and does not usually shed cells into the urine, so a clear cytology cannot rule it out. Only imaging — typically a contrast CT of the kidneys — can do that job.
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Mohammed Imran
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
A word on a lab report is not a diagnosis
Every kidney case at CION is read by a tumour board before anything is booked. Free first consultation, 45 minutes, and no commitment to start treatment.
Urine cytology results — what each line means, and what happens next
Laboratories use a standard reporting framework, so the wording below is close to what you will see, though it varies a little between labs. Read this to understand the conversation you are about to have, not to decide for yourself. Only a doctor who has seen your report and your images can say which row applies to you.
| What the report says | What it usually means | What usually happens next |
|---|---|---|
| Negative for high-grade urothelial carcinoma | No clearly abnormal cells were seen in this sample. | Reassuring, but not conclusive. Low-grade tumours shed near-normal cells, so if the bleeding or the imaging still points to the upper tract, the work-up continues rather than stopping here. |
| Unsatisfactory or non-diagnostic | Too few cells, or cells too degenerate to read. | The sample is repeated, with advice on timing and on getting it to the laboratory quickly. This is a comment on the specimen, not on you. |
| Atypical urothelial cells | Cells that are neither clearly normal nor clearly cancerous. | Common, and often explained by a stone, an infection, a catheter or a recent procedure. Any infection is treated, the test is usually repeated, and the result is read next to the scan. |
| Suspicious for high-grade urothelial carcinoma | The changes point towards cancer but fall short of a confident call. | Acted on as a positive result. Imaging of the whole urinary tract, plus a camera examination, which is coordinated for you with specialist urology partners. |
| High-grade urothelial carcinoma | Clearly malignant cells from the lining of the tract. | The source has to be located — bladder, ureter or renal pelvis. CT urography with a camera examination, and washings or a small tissue sample taken from the upper tract where that is where suspicion lies. |
| Features suggesting a low-grade urothelial tumour | A hint of a low-grade lesion, which cytology cannot confirm on its own. | Imaging and direct inspection carry the diagnosis here. Low-grade tumours are usually found on the scan or through the camera rather than in the urine. |
The cytology, the urine and blood tests, the ultrasound, CT and MRI and the tumour-board review are delivered in-house at CION. Cystoscopy, ureteroscopy, PET-CT and any surgery to the kidney or ureter are coordinated for you with specialist urology and uro-oncology partners, and may be billed at the partner centre. We put an indicative cost in writing before anything is booked, and check Aarogyasri, CGHS, ESI and insurance eligibility with you first.
From the urine sample to an answer — how the test is actually used
None of this should happen in a hurry, and none of it should happen without being explained to you first.
Deciding that cytology is worth sending
Cytology is ordered when a urothelial tumour is genuinely on the list, most often because of blood in the urine or a filling defect on a scan. It is not sent by reflex, and it is not sent for someone with no symptoms and a normal scan. If nobody has told you which possibility the test is chasing, that is a fair question to ask before you give the sample.
Giving the sample so it can actually be read
You pass urine into a sterile container, and it goes to the laboratory promptly or is fixed straight away, because cells break down quickly outside the body. The first urine of the morning is usually avoided, since cells that sat in the bladder overnight are degenerate. You may be asked for samples on more than one day. Tell the team about any infection, stone, catheter, recent procedure or past radiation, because all of these change how cells look.
What the pathologist is looking for
The sample is concentrated, fixed and stained, and the loose cells are examined for changes in size, shape and nucleus. The report is graded along a standard scale, from negative through atypical and suspicious to a confident call of high-grade cancer. A result takes days rather than hours, and it should be given to you with an explanation, not left as a line in a portal.
Reading it next to everything else
Cytology is never read alone. It sits beside CT urography or a contrast CT of the kidneys, your kidney-function bloods and the rest of the urine work-up, all of which we cover on our page about blood and urine tests in kidney cancer. NCCN guidance places cytology alongside imaging and direct inspection in the work-up of a suspected upper tract tumour rather than as a test that stands on its own. At CION the whole set goes to a uro-oncology tumour board before anything is recommended.
Finding the source when cells are abnormal
Abnormal cells prove that something is shedding them, not where it sits. The tract is inspected with a camera, and where the renal pelvis or ureter is suspected, washings or a small sample can be taken from that side directly. Those camera procedures are coordinated for you with specialist urology and uro-oncology partners. What follows from a confirmed diagnosis is set out on our kidney cancer treatment in Hyderabad page.
What cytology still cannot do. It cannot tell you where in the tract the cells came from, it cannot stage a tumour, it cannot measure how deep one has grown, and it cannot exclude the common kidney cancer, which does not shed into urine at all. Treat it as one piece of evidence that is very useful when positive and only partly reassuring when negative. Where treatment is later needed, systemic therapy and radiation are delivered in-house by our own team, while surgery, ablation and PET-CT are coordinated with specialist partners.
Ask what your result changes before you accept another test
Every case at CION goes to a tumour board, not one doctor's opinion. If a repeat sample would not alter your plan, we will tell you that plainly.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.Questions people ask about urine cytology
Does urine cytology detect kidney cancer?
Only one kind of it. Urine cytology looks for abnormal cells shed from the urothelium, the lining of the renal pelvis, ureter, bladder and urethra. It can therefore pick up urothelial carcinoma of the renal pelvis, which starts in that lining. It does not reliably detect renal cell carcinoma, the common kidney cancer that grows from the filtering tubules of the kidney itself, because those tumours do not usually shed cells into the urine. A normal cytology result says nothing about whether a renal cell carcinoma is present. That question is answered by a contrast CT of the kidneys, not by a urine test.
What does urine cytology test for?
It is a microscope test on the cells floating in your urine. A pathologist examines them for changes in size, shape and in the appearance of the nucleus that suggest a urothelial cancer. It is at its most useful for high-grade tumours and for carcinoma in situ, a flat cancer of the lining that is difficult to see on imaging. It is usually ordered alongside imaging when there is blood in the urine, or when a scan shows a filling defect in the renal pelvis or ureter. It is a test that supports a diagnosis. It is not a screening test for people with no symptoms and a normal scan.
Can urine cytology be negative and still be cancer?
Yes, and this is the most important thing to understand about the test. Cytology depends on a tumour shedding recognisable cells, and low-grade urothelial tumours shed cells that look close to normal, so they are often missed. A tumour sitting high in the renal pelvis may also shed very few cells into a voided sample. A negative result therefore lowers the suspicion but does not clear you. If the imaging or the bleeding still points to a problem, the work-up continues with CT urography and, where needed, a direct look inside the upper tract. A normal cytology is never the end of the matter on its own.
How is a urine sample collected for cytology?
Usually you pass urine into a sterile container at the clinic, and the sample goes to the laboratory promptly or is fixed straight away, because cells break down quickly once they leave the body. The first urine of the morning is generally avoided, because cells that have sat in the bladder overnight are degenerate and hard to read. You may be asked for samples on more than one day to improve the chance of catching abnormal cells. Tell the team if you have a urine infection, a stone or a catheter, or have recently had a bladder procedure or radiation, because all of these change how the cells look.
What does an atypical urothelial cells result mean?
It means the pathologist saw cells that are not clearly normal and not clearly cancerous. It is a recognised reporting category rather than a hedge, and it is common. Stones, infection, a catheter, recent instrumentation, radiation or earlier treatment inside the bladder can all irritate the lining and make ordinary cells look abnormal. An atypical result is a reason to look further, not a diagnosis. Your team will read it next to your scan, your urine and blood results and your symptoms, and will usually treat any infection and repeat the test. Ask what is being ruled in or out before you accept a repeat sample.
What happens after a positive urine cytology result?
A positive cytology tells you that abnormal urothelial cells are present somewhere along the urinary tract. It does not tell you where. The next job is to find the source, which means imaging of the whole tract, usually a CT urogram, together with a camera examination of the bladder and, where the upper tract is suspected, of the ureter and renal pelvis. Washings or a small tissue sample can be taken at the same sitting. At CION the imaging, the urine and blood tests and the tumour board review sit with our own team, while the camera procedures are coordinated for you with specialist urology partners.
This page is general health information about urine cytology and renal pelvis tumours. It is not a diagnosis and it cannot replace a specialist review of your own reports and images. Only a doctor who has seen your cytology, your scans and your kidney-function results can say what your result means. If you have blood in your urine, please arrange a review promptly rather than waiting — particularly if you also have loin pain, unexplained weight loss or a persistent fever.